8-KRegulation FDExhibits & Filings

CoreWeave, Inc. 8-K Report, Regulation FD Disclosure (Jul 7, 2025)

Filed July 7, 2025For Securities:CRWV

Summary

CoreWeave, Inc. (CRWV) has filed an 8-K report on July 7, 2025, primarily to disclose a significant corporate development: the entry into an Agreement and Plan of Merger with Core Scientific, Inc. This announcement, made via a joint press release, indicates a potential acquisition or business combination. The filing serves as formal notification to the market and includes important details regarding the transaction, such as the nature of the agreement and where investors can find further information. Investors should note that this is a preliminary announcement, and comprehensive details, including financial terms and strategic rationale, will be elaborated upon in subsequent filings, particularly a Form S-4 registration statement that will include a proxy statement/prospectus. The transaction is subject to customary closing conditions, including regulatory approvals and stockholder approval from Core Scientific. The filing also highlights the extensive forward-looking statements and associated risks that investors should consider. These risks encompass integration challenges, potential litigation, business disruptions, and market-specific regulatory and economic factors relevant to the AI, data center, and cryptocurrency industries. Investors are strongly advised to review all forthcoming SEC filings from both CoreWeave and Core Scientific for a complete understanding of the proposed merger's implications and risks.

Key Highlights

  • 1CoreWeave, Inc. announces entry into an Agreement and Plan of Merger with Core Scientific, Inc.
  • 2The announcement was made via a joint press release filed as an exhibit to the 8-K.
  • 3This transaction signifies a potential acquisition or business combination between the two companies.
  • 4Further details and required regulatory filings, including a Form S-4 registration statement, will be made available.
  • 5The proposed transaction is subject to customary closing conditions, including regulatory and stockholder approvals.
  • 6The filing includes extensive forward-looking statements and a detailed discussion of associated risks.
  • 7Investors are urged to review all forthcoming SEC filings for comprehensive information.

Frequently Asked Questions

The primary purpose of this 8-K filing is to formally announce CoreWeave, Inc.'s entry into an Agreement and Plan of Merger with Core Scientific, Inc. It serves as a public disclosure of this significant corporate development and directs investors to where they can find more information.

The merger is subject to customary closing conditions. These typically include obtaining necessary regulatory approvals and securing the approval of Core Scientific's stockholders. The filing also references other conditions that will be detailed in future filings.

More detailed information will be provided in subsequent SEC filings, most notably a registration statement on Form S-4 filed by CoreWeave, which will include a proxy statement of Core Scientific that also constitutes a prospectus of CoreWeave. Investors are encouraged to monitor the SEC's EDGAR database and the investor relations sections of both CoreWeave's and Core Scientific's websites for these filings.

The filing outlines numerous risks, including the possibility that the transaction may not be completed on anticipated terms, delays in completion, difficulties in integrating the businesses, potential litigation, business disruptions, adverse reactions from partners, and adverse legislative, regulatory, and economic developments affecting the AI, data center, and cryptocurrency industries. Investors should refer to the 'Forward-Looking Statements' section and specific risk factor disclosures in previous filings for a comprehensive list.